Note The agentic-doc Python library is now legacy. Please migrate to the new landingai-ade library, which is now the official Python library for Agentic Document Extraction and supports our newer API ...

Cellebrite DI's (NASDAQ:CLBT) stock up by 3.4% over the past three months. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals usually ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Cellebrite remains a "Buy" as federal demand rebounds and platform adoption accelerates, supporting a strong long-term growth outlook. The federal segment returned to year-over-year growth in Q3, ...

Cellebrite delivered strong financial results in Q3 2025, exceeding analyst expectations with revenue of $126 million, an 18% increase year-over-year. Subscription revenue, a key focus area for the ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Cellebrite DI Ltd. engages in the provision of digital investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital ...

Understand the cash flow statement for Cellebrite DI Ltd. (CLBT), learn where the money comes from and how the company spends it.